Nicotine Replacement Combined with a Novel Compound (ProBAN) for Smoking Cessation: A Pilot Study | Zendy

Richard Leigh | Zendy; Norman M Viner | Zendy; Gerard Cox | Zendy; Jeffrey Balon | Zendy; Douglas Wilson | Zendy; Denise O’Shaughnessy | Zendy; Corinne Walker | Zendy; Gerry Brosky | Zendy; Malcolm R. Sears | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Nicotine Replacement Combined with a Novel Compound (ProBAN) for Smoking Cessation: A Pilot Study

Author(s) -

Richard Leigh,

Norman M Viner,

Gerard Cox,

Jeffrey Balon,

Douglas Wilson,

Denise O’Shaughnessy,

Corinne Walker,

Gerry Brosky,

Malcolm R. Sears

Publication year - 2001

Publication title -

canadian respiratory journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.675

H-Index - 53

eISSN - 1916-7245

pISSN - 1198-2241

DOI - 10.1155/2001/947097

Subject(s) - medicine , nicotine replacement therapy , smoking cessation , nicotine , nicotine gum , placebo , abstinence , odds ratio , randomized controlled trial , concomitant , anesthesia , adverse effect , nicotine withdrawal , physical therapy , psychiatry , alternative medicine , pathology

Smoking cessation rates with available pharmacological therapies remain suboptimal. Anecdotal observations with a combination of sublingual pralidoxime and ipratropium (ProBAN) suggested that these agents in combination with nicotine gum improved quit rates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research